Based on the Pharma-Bio Serv Inc stock forecast from 0 analysts, the average analyst target price for Pharma-Bio Serv Inc is not available over the next 12 months. Pharma-Bio Serv Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Pharma-Bio Serv Inc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Pharma-Bio Serv Inc’s stock price was USD 0.55. Pharma-Bio Serv Inc’s stock price has changed by +0.00% over the past week, +14.58% over the past month and -39.56% over the last year.
No recent analyst target price found for Pharma-Bio Serv Inc
No recent average analyst rating found for Pharma-Bio Serv Inc
Company Overview Pharma-Bio Serv Inc
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico. Read Less
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, tech...Read More
Frequently Asked Questions About Pharma-Bio Serv Inc (PBSV) Stock
Stock Target Advisor's fundamental analysis for Pharma-Bio Serv Inc's stock is Neutral.
PBSV stock's dividend yield is 15.46%.
Our analysis grades PBSV stock's dividend yield at A+. This means that PBSV stock's dividend yield is above 100% of the stocks in the Health Information Services sector in the OTC exchange.
Based on this PBSV may be a good dividend stock for its sector.
Unfortunately we do not have enough data on PBSV's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on PBSV's stock to indicate if its overvalued.
The last closing price of PBSV's stock was USD 0.55.
The most recent market capitalization for PBSV is USD 0.01B.
Unfortunately we do not have enough analyst data on PBSV's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pharma-Bio Serv Inc's stock.
As per our most recent records Pharma-Bio Serv Inc has 100 Employees.
Pharma-Bio Serv Inc's registered address is Pharma-Bio Serv Building, Dorado, PR, United States, 00646.
You can get more information about it from Pharma-Bio Serv Inc's website at https://www.pharmabioserv.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Pharma-Bio Serv Inc (PBSV) Stock
Stock Target Advisor's fundamental analysis for Pharma-Bio Serv Inc's stock is Neutral.
PBSV stock's dividend yield is 15.46%.
Our analysis grades PBSV stock's dividend yield at A+. This means that PBSV stock's dividend yield is above 100% of the stocks in the Health Information Services sector in the OTC exchange.
Based on this PBSV may be a good dividend stock for its sector.
Unfortunately we do not have enough data on PBSV's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on PBSV's stock to indicate if its overvalued.
The last closing price of PBSV's stock was USD 0.55.
The most recent market capitalization for PBSV is USD 0.01B.
Unfortunately we do not have enough analyst data on PBSV's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pharma-Bio Serv Inc's stock.
As per our most recent records Pharma-Bio Serv Inc has 100 Employees.
Pharma-Bio Serv Inc's registered address is Pharma-Bio Serv Building, Dorado, PR, United States, 00646.
You can get more information about it from Pharma-Bio Serv Inc's website at https://www.pharmabioserv.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PBSV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
